Table 2.
Site of origin | Case ID | Tumor histology | Histologic component | PAX8 | CK7 | GATA3 | TTF-1 | ER | PR | Calretinin | CD10 | WT1 | p53 | MMR | HNF1b | CK20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mesonephric cervix | CX8 | Mesonephric | P | P | N | N | P | P | N | WT | N | |||||
CX17 | Mesonephric | |||||||||||||||
CX26 | Mixed mesonephric and endometrioid | Mesonephric | N | N | N | N | P | R | ||||||||
Endometrioid | N | N | P | P | ||||||||||||
CX33 | Mesonephric | P | N | N | P | N | WT | |||||||||
CX44 | Mesonephric | N | N | N | N | P | ||||||||||
CX58 | Mesonephric carcinosarcoma | P | P | N | N | P | P | WT | R | |||||||
CX62 | Mesonephric | P | P | P | N | N | N | N | P | N | WT | N | ||||
CX67 | Mesonephric | N | N | R | ||||||||||||
Mesonephric-like ovary | OV2 | Mixed mesonephric-like and serous borderline tumor | Mesonephric | P | P | P | N | N | N | N | WT | R | N | |||
Serous | P | WT | ||||||||||||||
OV19 | Mixed mesonephric-like and low-grade serous carcinoma | Mesonephric | P | P | N | N | N | N | N | N | ||||||
Serous | P | P | P | |||||||||||||
OV21 | Mixed mesonephric-like and mucinous borderline tumor | Mesonephric | P | P | P | P | N | N | N | P | N | P | N | |||
Mucinous | P | P | N | N | P | |||||||||||
OV34 | Mesonephric-like | P | P | P | N | N | N | WT | R | |||||||
OV50 | Mesonephric-like | P | P | P | P | N | N | N | P | N | WT | R | P | |||
OV57 | Mesonephric-like | P | P | P | N | R | ||||||||||
OV66 | Mesonephric-like | P | P | P | P | N | N | N | N | N | WT | R | P | N | ||
OV70 | Mesonephric-like | P | N | |||||||||||||
OV73 | Mesonephric-like | P | P | P | P | F | N | N | N | N | R | N | ||||
OV74 | Mixed mesonephric-like and serous borderline tumor/low-grade serous carcinoma | Mesonephric | P | P | N | P | N | N | P | N | P | |||||
Serous | P | P | N | N | P | P | N | P | P | |||||||
OV75 | Mixed mesonephric-like and mucinous borderline tumor | Mesonephric | P | P | P | P | F | N | N | WT | R | N | ||||
Mucinous | P | P | P | P | N | N | N | WT | R | P | ||||||
OV77 | Mesonephric-like | P | N | N | N | N | WT | R | ||||||||
OV79 | Mesonephric-like carcinosarcoma | P | N | N | N | N | ||||||||||
OV80 | Mesonephric-like | P | P | P | P | N | N | P | N | N | ||||||
OV81 | Mesonephric-like | P | P | N | N | N | N | WT | ||||||||
Mesonephric-like endometrium | EMI | Mesonephric-like | P | N | F | N | N | |||||||||
EM36 | Mesonephric-like | P | N | N | N | N | N | |||||||||
EM52 | Mesonephric-like | P | P | P | N | N | N | P | WT | R | N | N | ||||
EM59 | Mesonephric-like | P | P | P | N | N | N | P | R | |||||||
EM61 | Mesonephric-like | P | N | N | N | N | N | R | N | |||||||
EM63 | Mesonephric-like carcinosarcoma | N | R | |||||||||||||
EM64 | Mesonephric-like | P | N | N | N | WT | R | |||||||||
EM65 | Mesonephric-like carcinosarcoma | N | R | |||||||||||||
EM68 | Mesonephric-like | P | P | P | N | N | N | WT | N | |||||||
EM69 | Mesonephric-like | P | P | N | N | N | WT | R | N | |||||||
EM71 | Mesonephric-like | P | P | N | N | N | WT | R | N | |||||||
EM72 | Mesonephric-like | P | P | N | N | N | R | N | ||||||||
EM76 | Mesonephric-like | P | P | F | N | WT | R |
ER estrogen receptor, F focal, MMR DNA mismatch repair proteins, N negative, P positive, PR progesterone receptor, R retained, WT wild-type. Blank not performed.